TYK Medicines Wins Approval for Full H-Share Circulation in Hong Kong

TYK Medicines, Inc. Class H ( (HK:2410) ) has provided an update.

TYK Medicines, Inc., a PRC-incorporated joint stock company listed in Hong Kong, operates through H shares on the Stock Exchange of Hong Kong. Its share capital has comprised both H shares and unlisted shares, enabling participation from both public investors and private venture capital stakeholders.

The company has received approval from the Hong Kong Stock Exchange to list 4,608,000 converted H shares, representing previously unlisted shares held by a single shareholder. Following this conversion, all 380,065,818 shares of the company will be H shares, simplifying the capital structure and completing full circulation of H shares, which may enhance liquidity and accessibility for investors.

The most recent analyst rating on (HK:2410) stock is a Hold with a HK$13.50 price target. To see the full list of analyst forecasts on TYK Medicines, Inc. Class H stock, see the HK:2410 Stock Forecast page.

More about TYK Medicines, Inc. Class H

TYK Medicines, Inc. is a joint stock company incorporated in the People’s Republic of China and listed in Hong Kong under stock code 2410. The company has H shares traded on the Hong Kong Stock Exchange and historically also had unlisted shares, reflecting a capital structure that combines public market financing with private investment participation.

Average Trading Volume: 3,026,248

Technical Sentiment Signal: Sell

Current Market Cap: HK$4.83B

For a thorough assessment of 2410 stock, go to TipRanks’ Stock Analysis page.